Yusuke Aoki1,2,3, Yasunori Tome4, Qinghong Han1, Jun Yamamoto1,2, Kazuyuki Hamada1,2, Noriyuki Masaki1,2, Yutaro Kubota1,2, Michael Bouvet2, Kotaro Nishida3, Robert M Hoffman5,2. 1. AntiCancer Inc, San Diego, CA, U.S.A. 2. Department of Surgery, University of California San Diego, La Jolla, CA, U.S.A. 3. Department of Orthopedic Surgery, Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan. 4. Department of Orthopedic Surgery, Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan all@anticancer.com yastome@med.u-ryukyu.ac.jp. 5. AntiCancer Inc, San Diego, CA, U.S.A.; all@anticancer.com yastome@med.u-ryukyu.ac.jp.
Abstract
BACKGROUND/AIM: Methionine addiction is a fundamental and general hallmark of cancer cells, which require exogenous methionine, despite large amounts of methionine synthesized endogenously. 5-Methylthioadenosine phosphorylase (MTAP) plays a principal role as an enzyme in the methionine-salvage pathway, which produces methionine and adenine from methylthioadenosine and is deleted in 27.5% to 37.5% of osteosarcoma patients. MATERIALS AND METHODS: Human osteosarcoma cell lines U2OS, SaOS2, MNNG/HOS (HOS) and 143B, were used. The MTAP gene was knocked out in U2OS with CRISPR/Cas9. 143B and HOS have an MTAP deletion and SaOS2 is positive for MTAP. MTAP was determined by western blotting. The four cell lines were compared for sensitivity to recombinant methioninase (rMETase). RESULTS: MTAP-deleted osteosarcoma cell lines MNNG/HOS and 143B were significantly more sensitive to rMETase than MTAP-positive osteosarcoma cell lines U2OS and SaOS2. In addition, MTAP knock-out U2OS cells were more sensitive to rMETase than the parental MTAP-positive U2OS cells. CONCLUSION: The present results demonstrated that the absence of MTAP sensitizes osteosarcoma cells to methionine restriction by rMETase, a promising clinical strategy. Copyright
BACKGROUND/AIM: Methionine addiction is a fundamental and general hallmark of cancer cells, which require exogenous methionine, despite large amounts of methionine synthesized endogenously. 5-Methylthioadenosine phosphorylase (MTAP) plays a principal role as an enzyme in the methionine-salvage pathway, which produces methionine and adenine from methylthioadenosine and is deleted in 27.5% to 37.5% of osteosarcoma patients. MATERIALS AND METHODS: Human osteosarcoma cell lines U2OS, SaOS2, MNNG/HOS (HOS) and 143B, were used. The MTAP gene was knocked out in U2OS with CRISPR/Cas9. 143B and HOS have an MTAP deletion and SaOS2 is positive for MTAP. MTAP was determined by western blotting. The four cell lines were compared for sensitivity to recombinant methioninase (rMETase). RESULTS: MTAP-deleted osteosarcoma cell lines MNNG/HOS and 143B were significantly more sensitive to rMETase than MTAP-positive osteosarcoma cell lines U2OS and SaOS2. In addition, MTAP knock-out U2OS cells were more sensitive to rMETase than the parental MTAP-positive U2OS cells. CONCLUSION: The present results demonstrated that the absence of MTAP sensitizes osteosarcoma cells to methionine restriction by rMETase, a promising clinical strategy. Copyright
Authors: Peter Kalev; Marc L Hyer; Stefan Gross; Zenon Konteatis; Chi-Chao Chen; Mark Fletcher; Max Lein; Elia Aguado-Fraile; Victoria Frank; Amelia Barnett; Everton Mandley; Joshua Goldford; Yue Chen; Katie Sellers; Sebastian Hayes; Kate Lizotte; Phong Quang; Yesim Tuncay; Michelle Clasquin; Rachel Peters; Jaclyn Weier; Eric Simone; Joshua Murtie; Wei Liu; Raj Nagaraja; Lenny Dang; Zhihua Sui; Scott A Biller; Jeremy Travins; Kevin M Marks; Katya Marjon Journal: Cancer Cell Date: 2021-01-14 Impact factor: 31.743
Authors: José M García-Castellano; Alberto Villanueva; John H Healey; Rebecca Sowers; Carlos Cordon-Cardo; Andrew Huvos; Joseph R Bertino; Paul Meyers; Richard Gorlick Journal: Clin Cancer Res Date: 2002-03 Impact factor: 12.531
Authors: Katya Marjon; Michael J Cameron; Phong Quang; Michelle F Clasquin; Everton Mandley; Kaiko Kunii; Michael McVay; Sung Choe; Andrew Kernytsky; Stefan Gross; Zenon Konteatis; Joshua Murtie; Michelle L Blake; Jeremy Travins; Marion Dorsch; Scott A Biller; Kevin M Marks Journal: Cell Rep Date: 2016-04-07 Impact factor: 9.423